Heart, Blood Pressure & Longevity News: What Headlines Claim vs. What the Data Really Shows.

In the landmark TIME trial published in The Lancet (PMID 36240838, N = 21,104), researchers randomly assigned 21,104 adults with high blood pressure to take their daily pills either in the morning (6:00–10:00 A.M.) or at night (8:00 P.M.–midnight) and followed them for 5.2 years . The result? 3.4% of the bedtime group had a heart attack, stroke, or vascular death compared to 3.7% of the morning group—a statistical tie (0.3% absolute difference, Hazard Ratio 0.95, p = 0.53) . The Canadian BedMed trial in JAMA confirmed the exact same tie .

Let’s honor both halves of the science. First, in the NEJM SAMSON trial (PMID 33196154), researchers gave patients who had quit statins because of severe muscle aches 12 unmarked monthly bottles (4 with Atorvastatin 20 mg, 4 with an identical sugar pill, and 4 completely empty bottles) . Patients felt real pain—their pain scores jumped from 8.0 (no pill) to 16.3 on the statin—but their pain also jumped to 15.4 on the sugar pill (a 0.90 nocebo ratio) . Second, when you do have true pharmacological muscle soreness from a high-dose statin (like 40 mg or 80 mg), The Lancet RACING trial (PMID 35858640, N = 3,780) proved that stepping down to a moderate statin dose + generic ezetimibe 10 mg got more patients to an LDL under 55 mg/dL (72% vs. 58%) while cutting intolerance quitting by 44% (4.8% vs. 8.2%) !